ΠΡΡΠΈ ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΠΎΠΉ
ΠΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²ΠΎ ΡΡΠ°ΡΡΠΊΠΎΠ²ΡΡ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΎΠ² (69%) ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠ²Π½ΠΎ ΠΎΡΠ½ΠΎΡΡΡΡΡ ΠΊ Π½ΠΎΠ²ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌ ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΡΡΡΠΎΠ³ΠΎ ΠΏΡΠΈΠ΄Π΅ΡΠΆΠΈΠ²Π°ΡΡΡΡ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΉ, Π΄Π°Π½Π½ΡΡ Π² ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΠΎΠΌ ΠΏΠ»Π°Π½Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ . ΠΠ΄Π½Π°ΠΊΠΎ ΠΏΡΠΈ Π·Π°ΠΌΠ΅Π½Π΅ ΠΎΠ΄Π½ΠΈΡ ΠΈΠΠΠ‘ Π΄ΡΡΠ³ΠΈΠΌΠΈ Π² 21% ΡΠ»ΡΡΠ°Π΅Π² ΠΎΡΠΌΠ΅ΡΠ°Π»ΠΈΡΡ ΠΎΡΠΈΠ±ΠΊΠΈ Π² Π²ΡΠ±ΠΎΡΠ΅ ΡΠΊΠ²ΠΈΠ²Π°Π»Π΅Π½ΡΠ½ΡΡ Π΄ΠΎΠ·, ΡΡΠΎ ΠΎΡΡΠ°ΠΆΠ°Π΅Ρ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΠΊ Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΡΡ Π·Π½Π°Π½ΠΈΠΉ ΠΏΠΎ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΠ. ΠΠ»Ρ Π²Π½Π΅Π΄ΡΠ΅Π½ΠΈΡ Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΡΡ ΠΏΡΠ°ΠΊΡΠΈΠΊΡ Π½ΠΎΠ²ΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ²… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- Π‘ΠΏΠΈΡΠΎΠΊ ΡΠΎΠΊΡΠ°ΡΠ΅Π½ΠΈΠΉ
ΠΡΡΠΈ ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΠΎΠΉ (ΡΠ΅ΡΠ΅ΡΠ°Ρ, ΠΊΡΡΡΠΎΠ²Π°Ρ, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½Π°Ρ)
Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ.6.
ΠΠ°Π΄Π°ΡΠΈ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ.7.
ΠΠ°ΡΡΠ½Π°Ρ Π½ΠΎΠ²ΠΈΠ·Π½Π° ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ.7.
ΠΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠ°Ρ Π·Π½Π°ΡΠΈΠΌΠΎΡΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ.8.
ΠΠ½Π΅Π΄ΡΠ΅Π½ΠΈΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² Π² ΠΏΡΠ°ΠΊΡΠΈΠΊΡ.8.
ΠΡΠ±Π»ΠΈΠΊΠ°ΡΠΈΠΈ.8.
ΠΠΏΡΠΎΠ±Π°ΡΠΈΡ ΡΠ°Π±ΠΎΡΡ.9.
ΠΠ±ΡΠ΅ΠΌ ΠΈ ΡΡΡΡΠΊΡΡΡΠ° ΡΠ°Π±ΠΎΡΡ.9.
ΠΡΠ²ΠΎΠ΄Ρ.
1. Π€Π°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΡΡ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΠ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΠ΅Ρ ΡΡΡΠ΅ΡΡΠ²ΡΡΡΠΈΠΌ ΡΡΠ°Π½Π΄Π°ΡΡΠ°ΠΌ ΠΈ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΡΠΌ ΡΠΎΠ»ΡΠΊΠΎ Ρ 18−46% Π²Π·ΡΠΎΡΠ»ΡΡ ΠΈ 10−64% ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ². ΠΠ°ΠΈΠΌΠ΅Π½ΡΡΠ΅Π΅ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΠΈΠ΅ ΡΡΡΠ΅ΡΡΠ²ΡΡΡΠΈΠΌ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΡΠΌ ΠΎΡΠΌΠ΅ΡΠ°Π΅ΡΡΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ Π»Π΅Π³ΠΊΠΎΠΉ ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΡΡΡΠ΅ΠΉ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΠΎΠΉ (Π±ΠΎΠ»ΡΡΠ°Ρ ΡΠ°ΡΡΡ ΠΊΠΎΡΠΎΡΡΡ — Π΄ΠΎ 82% ΠΎΡ ΠΎΠ±ΡΠ΅Π³ΠΎ ΡΠΈΡΠ»Π°, Π²ΠΎΠΎΠ±ΡΠ΅ Π½Π΅ ΠΏΠΎΠ»ΡΡΠ°Π΅Ρ Π±Π°Π·ΠΈΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ) ΠΈ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΡΡΠΆΠ΅Π»ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ (75% ΠΊΠΎΡΠΎΡΡΡ ΠΏΠΎΠ»ΡΡΠ°ΡΡ Π½Π΅Π°Π΄Π΅ΠΊΠ²Π°ΡΠ½ΡΠ΅ Π΄ΠΎΠ·Ρ ΠΈΠΠΠ‘). ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π² Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² (ΠΈΠΠΠ‘+Π¬ΠΠΠ) ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠΊΠΎΡΠ΅Π΅ ΠΈΡΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΈΠ· ΠΏΡΠ°Π²ΠΈΠ»Π° Π΄Π»Ρ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΠ Ρ Π»ΡΠ±ΠΎΠΉ ΡΡΠΆΠ΅ΡΡΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ (1.5% Π²Π·ΡΠΎΡΠ»ΡΡ ΠΈ 7% ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² Ρ ΡΠΌΠ΅ΡΠ΅Π½Π½ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΠ, 0% Π²Π·ΡΠΎΡΠ»ΡΡ ΠΈ 5% ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² Ρ ΡΡΠΆΠ΅Π»ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΠ ΠΏΠΎΠ»ΡΡΠ°ΡΡ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ ΠΈΠΠΠ‘+Π¬ΠΠΠ). ΠΠ° Π΄ΠΎΠ»Ρ Π½Π΅ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ ΠΈΠ»ΠΈ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ ΠΎΠΏΠ°ΡΠ½ΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² ΠΏΡΠΈΡ ΠΎΠ΄ΠΈΡΡΡ 13.5% Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΠΉ.
2. ΠΠΎΠ²ΡΠ΅ ΠΌΠ΅ΡΠΎΠ΄Ρ ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ Π±Π°Π·ΠΈΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΠ — ΡΠΎΠ·Π΄Π°Π½ΠΈΠ΅ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΡΡ ΠΏΠ»Π°Π½ΠΎΠ² Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΈ ΠΎΠ±ΡΡΠ΅Π½ΠΈΠ΅ Π² «Π°ΡΡΠΌΠ°-ΡΠΊΠΎΠ»Π΅» ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ° ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ Π² 2,7 ΡΠ°Π·Π° ΡΠ²Π΅Π»ΠΈΡΠΈΡΡ Π΄ΠΎΠ»Ρ Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΠΉ, ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΡΡΠΈΡ ΡΡΡΠ΅ΡΡΠ²ΡΡΡΠΈΠΌ ΡΡΠ°Π½Π΄Π°ΡΡΠ°ΠΌ ΠΈ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΡΠΌ, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ ΡΠ»ΡΡΡΠΈΡΡ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ Π·Π° ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΈ ΡΠ½ΠΈΠ·ΠΈΡΡ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ ΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΠΉ Π·Π° ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΡΡ (ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΡΠΈΡΠΊ ΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΠΉ Π·Π° ΡΠΊΠΎΡΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠ½ΠΈΠ·ΠΈΠ»ΡΡ Π½Π° 91%, ΡΠΈΡΠΊ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΉ — Π½Π° 93%).
3. ΠΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²ΠΎ ΡΡΠ°ΡΡΠΊΠΎΠ²ΡΡ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΎΠ² (69%) ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠ²Π½ΠΎ ΠΎΡΠ½ΠΎΡΡΡΡΡ ΠΊ Π½ΠΎΠ²ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌ ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΡΡΡΠΎΠ³ΠΎ ΠΏΡΠΈΠ΄Π΅ΡΠΆΠΈΠ²Π°ΡΡΡΡ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΉ, Π΄Π°Π½Π½ΡΡ Π² ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΠΎΠΌ ΠΏΠ»Π°Π½Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ . ΠΠ΄Π½Π°ΠΊΠΎ ΠΏΡΠΈ Π·Π°ΠΌΠ΅Π½Π΅ ΠΎΠ΄Π½ΠΈΡ ΠΈΠΠΠ‘ Π΄ΡΡΠ³ΠΈΠΌΠΈ Π² 21% ΡΠ»ΡΡΠ°Π΅Π² ΠΎΡΠΌΠ΅ΡΠ°Π»ΠΈΡΡ ΠΎΡΠΈΠ±ΠΊΠΈ Π² Π²ΡΠ±ΠΎΡΠ΅ ΡΠΊΠ²ΠΈΠ²Π°Π»Π΅Π½ΡΠ½ΡΡ Π΄ΠΎΠ·, ΡΡΠΎ ΠΎΡΡΠ°ΠΆΠ°Π΅Ρ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΠΊ Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΡΡ Π·Π½Π°Π½ΠΈΠΉ ΠΏΠΎ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΠ.
4. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ (ΠΈΠ½Π³Π°Π»ΡΡΠΈΠΎΠ½Π½ΡΠ΅ ΠΠΠ‘ + Ρ2-Π°Π³ΠΎΠ½ΠΈΡΡΡ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ) ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π΄Π»Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΠ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ ΡΠ»ΡΡΡΠΈΡΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΠΈ ΠΈ ΡΡΠ΅ΠΏΠ΅Π½Ρ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ Π·Π° ΡΠΈΠΌΠΏΡΠΎΠΌΠ°ΠΌΠΈ ΠΠ (Π² 3,3 ΡΠ°Π·Π° Ρ Π²Π·ΡΠΎΡΠ»ΡΡ ΠΈ Π² 4,4 ΡΠ°Π·Π° Ρ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ²), ΡΠ½ΠΈΠ·ΠΈΡΡ Π±ΠΎΠ»Π΅Π΅ ΡΠ΅ΠΌ Π² 10 ΡΠ°Π· ΡΠΈΡΠ»ΠΎ ΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΠΉ Π·Π° Π½Π΅ΠΎΡΠ»ΠΎΠΆΠ½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΡΡ (ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ΅ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΡΠΈΡΠΊΠ° ΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΠΉ Π·Π° ΡΠΊΠΎΡΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΡΡ Ρ Π²Π·ΡΠΎΡΠ»ΡΡ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ 97.8% ΠΈ 94.4%, ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ), ΠΏΠΎΡΡΠΈ Π² 2 ΡΠ°Π·Π° ΡΠ»ΡΡΡΠΈΡΡ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎ ΠΆΠΈΠ·Π½ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ (Ρ 43.4±19.5% ΡΠ²Π΅Π»ΠΈΡΠΈΠ»ΠΎΡΡ Π΄ΠΎ 83.4±12.55%). Π£Π»ΡΡΡΠ΅Π½ΠΈΠ΅ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΆΠΈΠ·Π½ΠΈ ΠΎΠΊΠ°Π·Π°Π»ΠΎΡΡ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΌ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΡΡΠΆΠ΅Π»ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΠ (Ρ 37.6±20 Π΄ΠΎ 80.7±14%).
5. Π ΡΠ΅Π»ΠΎΠΌ, ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π½ΠΎΠ²ΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΠ («Π°ΡΡΠΌΠ°-ΡΠΊΠΎΠ»Π°», ΡΠΎΠ·Π΄Π°Π½ΠΈΠ΅ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΡΡ ΠΏΠ»Π°Π½ΠΎΠ² Π»Π΅ΡΠ΅Π½ΠΈΡ, Π²Π½Π΅Π΄ΡΠ΅Π½ΠΈΠ΅ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π΄Π»Ρ Π±Π°Π·ΠΈΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΠ, ΠΎΠ±ΡΡΠ΅Π½ΠΈΠ΅ ΡΡΠ°ΡΡΠΊΠΎΠ²ΡΡ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΎΠ²) ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ ΡΠ²Π΅Π»ΠΈΡΠΈΡΡ ΡΠΈΡΠ»ΠΎ ΡΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΠΉ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ°ΡΡΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΡΠ΅Π΄ΡΡΠ² ΠΈ ΡΠ»ΡΡΡΠΈΡΡ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΡ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ .
ΠΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΈ:
1. Π Π»Π΅ΡΠ΅Π±Π½ΠΎ-ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΡΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΡΡ Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎ ΡΠ΅Π³ΡΠ»ΡΡΠ½ΠΎ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· Π²ΡΠ°ΡΠ΅Π±Π½ΡΡ Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΠΉ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΠ, Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΠΉ Π½Π° ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΡ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΡΡΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ. ΠΠ° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΈ ΡΡΠΎΠΉ ΡΠ°Π±ΠΎΡΡ ΡΠ»Π΅Π΄ΡΠ΅Ρ ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°ΡΡ ΠΎΠ±ΡΡΠ΅Π½ΠΈΠ΅ ΡΡΠ°ΡΡΠΊΠΎΠ²ΡΡ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΎΠ², Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΠ΅ Π½Π° ΠΈΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠ΅ ΡΠΈΠΏΠΈΡΠ½ΡΡ ΠΎΡΠΈΠ±ΠΎΠΊ Π² ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΠ ΠΈ ΠΎΠ±ΡΡΠ΅Π½ΠΈΠ΅ Π²ΡΠ°ΡΠ΅ΠΉ Π½ΠΎΠ²ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌ Π»Π΅ΡΠ΅Π½ΠΈΡ.
2. ΠΠ»Ρ Π²Π½Π΅Π΄ΡΠ΅Π½ΠΈΡ Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΡΡ ΠΏΡΠ°ΠΊΡΠΈΠΊΡ Π½ΠΎΠ²ΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΠ, Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎ Π² Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΡΡ Π»Π΅ΡΠ΅Π±Π½ΡΡ ΡΡΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΡΡ , ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡ ΠΏΠΎΡΡΠΎΡΠ½Π½ΠΎΠ΅ Π΅ΠΆΠ΅Π³ΠΎΠ΄Π½ΠΎΠ΅ ΠΎΠ±ΡΡΠ΅Π½ΠΈΠ΅ ΡΡΠ°ΡΡΠΊΠΎΠ²ΡΡ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΎΠ² (ΠΎΠ΄Π½ΠΎΠ΄Π½Π΅Π²Π½ΡΠ΅ Π»Π΅ΠΊΡΠΈΠΈ ΠΈ ΡΠ΅ΠΌΠΈΠ½Π°ΡΡ) Ρ ΠΏΡΠΈΠ²Π»Π΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΡΡΠΎΠ²-ΠΏΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΎΠ² ΠΈ/ΠΈΠ»ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ°ΡΠΌΠ°ΠΊΠΎΠ»ΠΎΠ³ΠΎΠ².
3. Π ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ°Ρ Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΠΎΠ±ΡΡΠ΅Π½ΠΈΡ Π²ΡΠ΅Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Π² «Π°ΡΡΠΌΠ°-ΡΠΊΠΎΠ»Π°Ρ » ΠΈ ΡΠΎΡΡΠ°Π²Π»Π΅Π½ΠΈΠ΅ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΡΡ ΠΏΠ»Π°Π½ΠΎΠ² Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΠ Π΄Π»Ρ ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠ΅Π½ΠΈΡ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π² Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΡΡ ΡΡΠ»ΠΎΠ²ΠΈΡΡ Ρ ΡΠ΅Π»ΡΡ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ ΠΎΠ±ΠΎΡΡΡΠ΅Π½ΠΈΠΉ ΠΠ.
4. Π‘Π»Π΅Π΄ΡΠ΅Ρ Π±ΠΎΠ»Π΅Π΅ ΡΠΈΡΠΎΠΊΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°ΡΡ Π² Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΠ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ (ΠΈΠΠΠ‘ + Ρ2-Π°Π³ΠΎΠ½ΠΈΡΡΡ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ) ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ, ΠΊΠΎΡΠΎΡΡΠ΅ Π΄ΠΎΠ»ΠΆΠ½Ρ Π½Π°Π·Π½Π°ΡΠ°ΡΡΡΡ Π²Π·ΡΠΎΡΠ»ΡΠΌ Π±ΠΎΠ»ΡΠ½ΡΠΌ Ρ ΡΡΠΆΠ΅Π»ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΠ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠ°ΠΌΡ ΡΠΌΠ΅ΡΠ΅Π½Π½ΡΠΌ ΠΈ ΡΡΠΆΠ΅Π»ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΠ. ΠΠ·ΡΠΎΡΠ»ΡΠΌ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ Ρ Π»Π΅Π³ΠΊΠΈΠΌ ΠΈ ΡΠΌΠ΅ΡΠ΅Π½Π½ΠΎ.
— ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΡΡΠΈΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ Π°ΡΡΠΌΡ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΠΏΡΠ΅Π΄ΠΏΠΎΡΡΠΈΡΠ΅Π»ΡΠ½ΡΠΌ ΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΈ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅ΡΡΡ Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ ΠΈΠΠΠ‘ Π±Π΅Π· ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΠΈΠΈ Ρ Π¬ΠΠΠ.
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- L. et al. (1996) Evidence based medicine: what it is and what it isn’t. BMJ 312 (7023), 13 January, 71−72
- ΠΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½Π°Ρ Π°ΡΡΠΌΠ°, Π³Π»ΠΎΠ±Π°Π»ΡΠ½Π°Ρ ΡΡΡΠ°ΡΠ΅Π³ΠΈΡ. ΠΡΠ½ΠΎΠ²Π½ΡΠ΅ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ Π°ΡΡΠΌΡ: ΠΡΠ΅ΠΌΠΈΡΠ½Π°Ρ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ ΡΠ°Π½Π΅Π½ΠΈΡ, ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΉ ΠΈΠ½ΡΡΠΈΡΡΡ ΡΠ΅ΡΠ΄ΡΠ΅, Π»Π΅Π³ΠΊΠΈΠ΅ ΠΈ ΠΊΡΠΎΠ²Ρ. ΠΠ°ΡΡ 1993. ΠΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ 1996- ΠΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅ 1: 1−165.
- NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. NIH Publication No. 02−3659. February 2002- p. 1−177
- Asthma in America web site: www.asthmainamerica.com
- Asthma Insights & Reality in Europe web site: www.asthmaineurope.com
- Π§ΡΡΠ°Π»ΠΈΠ½ Π.Π. ΠΠ΅Π»Π°Ρ ΠΊΠ½ΠΈΠ³Π°. ΠΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ. Π ΠΎΡΡΠΈΡ 2003. Π: 2003. ΡΡΡ. 51−56. www.pulmonology.ru
- ΠΡΡ ΠΈΠΏΠΎΠ² Π.Π., ΠΠ΅ΠΌΠΈΠ΄ΠΎΠ²Π° Π. Π., ΠΠ°Π·Π°ΡΠ΅Π²Π° Π. Π., Π¦ΠΎΠΉ Π.Π. Π€Π°ΡΠΌΠ°ΠΊΠΎΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΎΡΠ΅Π½ΠΊΠ° ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΡΡ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌ ΠΈ Π²Π½Π΅Π΄ΡΠ΅Π½ΠΈΡ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΡΡ ΠΏΠ»Π°Π½ΠΎΠ² Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΠΎΠΉ. ΠΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ, 2002- № 1: 105−109
- Π§ΡΡΠ°Π»ΠΈΠ½ Π.Π., Π¦ΠΎΠΉ Π.Π., ΠΡΡ ΠΈΠΏΠΎΠ² Π. Π. Π€Π°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ Π°ΡΡΠΌΡ Ρ ΠΏΠΎΠ·ΠΈΡΠΈΠΈ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Ρ Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΡΡΠ². Π’Π΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°ΡΡ ΠΈΠ², 2003, 3, Ρ. 73−77
- Sackett, D.L. et al. (1996) Evidence based medicine: what it is and what it isn’t. BMJ 312 (7023), 13 January, 71−72)
- Emond S. D" Camargo C.A., Nowak R.M. Advances, Opportunities, and the New Asthma Guidelines. Annals of Emergency Medicine- Volume 31- Numbers- May 1998- p. 590−594.
- NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. NIH Publication No. 02−3659. February 2002- p. 1−177
- ΠΠ»ΠΎΠ±Π°Π»ΡΠ½Π°Ρ ΡΡΡΠ°ΡΠ΅Π³ΠΈΡ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΡ. Π., 2002, «ΠΡΠΌΠΎΡΡΠ΅ΡΠ°», 160 Ρ.
- The British Guidelines on Asthma Management: 1995 review and position statement. Thorax, 1997- 52 (suppl I): 1−21
- Difficult/therapy-resistant asthma. Eur. Respir. J. 1999- 13:1198−1208
- Canadian asthma consensus report, 1999. CMAJ 1999- 161 11 Suppl.- p. 1−62
- Π‘ΡΠ°Π½Π΄Π°ΡΡΡ (ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Ρ) Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ Π½Π΅ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ Π»Π΅Π³ΠΊΠΈΡ . ΠΠΎΠ΄ ΡΠ΅Π΄. Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΊΠ° Π ΠΠΠ Π. Π. Π§ΡΡΠ°Π»ΠΈΠ½Π°. Π., ΠΠ·Π΄Π°ΡΠ΅Π»ΡΡΡΠ²ΠΎ ΠΡΠ°Π½ΡΡ. 1999, 40 Ρ.
- Shrewsbury S, Π ΡΠΊΠ΅ S, Britton Π. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). BMJ, 20 MAY 2000: Vol 320- 1368−1379
- Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996−153:1481−8.
- ZetterstrOm O, Buhl R, Mellem H, Perpina M, Hedman J, O’Neill S, Peterson S. Symbicort (budesonide/formoterol in a single inhaler) improves asthma control and exacerbations rate in adult patients. Allergy 2001- 56(Suppl 68):281
- Aubier M, Pieters WR, Schlosser NJ, Steinmetz K-O. Salmeterol/fluticasone propionate (50/500 mug) in combination in a Diskus® inhaler (Seretide®) is effective and safe in the treatment of steroid-dependent asthma. Respir Med 1999−93:876−84
- Ericsson K, Bantje TA, Huber R, Borg S, Andersson F. Cost-effectiveness of budesonide and formoterol in a single inhaler compared to fluticasone in the treatment of asthma. Eur Respir J 2001- 18(Suppl 33): 157s.
- Barnes PJ. Effects of p2-agonists on inflammatory cells. Journal of Allergy and Clinical Immunology. 1999- Vol. 104: #2: 10−17.
- NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. NIH Publication No. 02−3659. February 2002- p. 1−177
- Canadian asthma consensus report, 1999. CMAJ 1999- 161 11 Suppl.- p. 1−62
- Gaining Optimal Asthma Control (GOAL) Study www.asthmaGOAL.com
- NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. NIH Publication No. 02−3659. February 2002- p. 1−177
- Stallberg B, Olsson P, Jolgersen LA, et al. Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing. Int J Clin Pract. 2003 Oct-57(8):656−61.
- Fitzgerald M, et al. Eur Respir J 2003- abstract presented at 13th European Respiratory Society Congress, 27 September -1 October 2003, Vienna, Austria
- Zetterstrom O, Buhl R, Mellem H, Perpina M, Hedman J, O’Neill S, Peterson S. Symbicort (budesonide/formoterol in a single inhaler) improves asthma control and exacerbations rate in adult patients. Allergy 2001- 56(Suppl 68):281
- Tal A, Simon G, Vermeulin GH et al. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Pediatr Pulmonol. 2002 Nov-34(5):342−50.
- Lallo UG., Malolepszy J, Kosma D et al. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. Chest. 2003 May-123(5):1480−7.
- NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. NIH Publication No. 02−3659. February 2002- p. 1−177
- Π‘ΡΠ°Π½Π΄Π°ΡΡΡ (ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Ρ) Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ Π½Π΅ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ Π»Π΅Π³ΠΊΠΈΡ . ΠΠΎΠ΄ ΡΠ΅Π΄. Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΊΠ° Π ΠΠΠ Π. Π. Π§ΡΡΠ°Π»ΠΈΠ½Π°. Π., ΠΠ·Π΄Π°ΡΠ΅Π»ΡΡΡΠ²ΠΎ ΠΡΠ°Π½ΡΡ. 1999, 40 Ρ.
- ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΠ° «ΠΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½Π°Ρ Π°ΡΡΠΌΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ. Π‘ΡΡΠ°ΡΠ΅Π³ΠΈΡ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ°» Π ΠΠ, ΠΏΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅, ΠΌΠ°ΠΉ 1998- 6 (2): 3−48.
- Π€Π΅Π΄Π΅ΡΠ°Π»ΡΠ½ΠΎΠ΅ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ ΠΏΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ ΡΡΠ΅Π΄ΡΡΠ² (ΡΠΎΡΠΌΡΠ»ΡΡΠ½Π°Ρ ΡΠΈΡΡΠ΅ΠΌΠ°). ΠΡΠΏΡΡΠΊ IV. ΠΠΎΡΠΊΠ²Π° 2003 Π³: Ρ. 194−195
- Peat JK, Haby Π, Spijker J, Berry G, Woolcock AJ. Prevalence of asthma in adults in Busselton, Western Australia. BMJ 1992−305:1326−9.
- Dubois P, Degrave E, Vandenplas O. Asthma and airway hyperresponsiveness among Belgian conscripts, 1978−91. Thorax 1998−53:101−5.
- Huovinen E, Kaprio J, Laitinen LA, Koskenvuo M. Incidence and prevalence of asthma among adult Finnish men and women of the Finnish Twin Cohort from 1975 to 1990, and their relation to hay fever and chronic bronchitis. Chest 1999−115:928−36.
- ΠΠΈΠ»ΠΈΡΠ΅Π½ΠΊΠΎ Π’.Π. ΠΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΡ // ΠΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½Π°Ρ Π°ΡΡΠΌΠ°/ ΠΠΎΠ΄ ΡΠ΅Π΄. Π. Π. Π§ΡΡΠ°Π»ΠΈΠ½Π°. Π.: ΠΠ³Π°Ρ, 1997.-Π’.1, ΠΠ». 14. — Π‘.400 — 423.
- ΠΠ΅ΡΠ΅Π½ΠΊΠΎ Π.Π. Π Π°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΡ Π² Π‘Π²Π΅ΡΠ΄Π»ΠΎΠ²ΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ. ΠΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ 2001 Π³. № 2 ΡΡΡ.50−55 «~ ' ~ ~
- ISAAC Steering Committee. «Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC.» Lancet. 1998−351:1225. etal. Op. cit.
- ΠΡΠΎΠΆΠΆΠ΅Π² M.E. ΠΠ΅Π² H.C. ΠΈ ΡΠΎΠ°Π²Ρ. Π‘ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΠΈ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΡ ΡΡΠ΅Π΄ΠΈ Π΄Π΅ΡΠ΅ΠΉ. ΠΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ, 2002 Π³. № 2 ΡΡΡ.42−46
- Asthma in America web site: www.asthmainamerica.com
- Π§ΡΡΠ°Π»ΠΈΠ½ Π.Π. ΠΠ΅Π»Π°Ρ ΠΊΠ½ΠΈΠ³Π°. ΠΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ. Π ΠΎΡΡΠΈΡ 2003. Π: 2003. ΡΡΡ. 51−56. www.pulmonology.ru
- Levy Π, Bell L. General practice audit of asthma in childhood. BMJ (Clin Res Ed) 1984−289:11 156.
- Gellert AR, Gellert SL, lliffe SR. Prevalence and management of asthma in a London inner city general practice. Br J Gen Pract 1990−40:197−201.
- Horn CR, Cochrane GM. Management of asthma in general practice. Respir Med 1989−83:67−70.
- Horn CR, Essex E, Hill P, Cochrane GM. Does urinary salbutamol reflect compliance with the aerosol regimen in patients with asthma? Respir Med 1989−83:15−8.
- Rand CS, Wise RA, Nides M, Simmons MS, Bleecker ER, Kusek JW, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992−146:1559−64.
- Spector SL, Kinsman R, Mawhinney H, Siegel SC, Rachelefsky GS, Katz RM, et al. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol 1986−77:65−70.
- Asthma in America web site: www.asthmainamerica.com
- Asthma Insights & Reality in Europe web site: www.asthmaineurope.com
- Blainey D, Lomas D, Beale A, Partridge M. The cost of acute asthma-how much is preventable? Health Trends 1990−22:151−3.
- Bucknall CE, Slack R, Godley CC, Mackay TW, Wright SC. Scottish Confidential Inquiry into Asthma Deaths (SCIAD), 1994−6. Thorax 1999−54:978−84.
- Burr ML, Davies BH, Hoare A, Jones A, Williamson I J, Holgate SK, et al. A confidential inquiry into asthma deaths in Wales. Thorax 1999−54:985−9.
- Strom BL, Ed. Pharmacoepidemiology. 3rd Edition. Chichester: John Wiley & Sons- 2000.
- Hallas J. Pharmacoepidemiology current opportunities and challenges. Norwegian Journal of Epidemiology 2001- 11 (1): 7−12
- Bergman U. Pharmacoepidemiology from description to quality assessment. Norwegian Journal of Epidemiology 2001- 11 (1): 31−36
- Anis AH- Lynd LD- Wang XH- et al. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 6-MAR-2001- 164(5): 625−31
- Stafford RS- Ma J- Finkelstein SN- Haver K- Cockburn I. National trends in asthma visits and asthma pharmacotherapy, 1978−2002. J Allergy Clin Immunol 01-APR-2003- 111(4): 729−35
- Lynd LD- Guh DP- Pare PD- Anis AH. Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. Chest 01-DEC-2002- 122(6): 1973−81
- Jepson G- Butler T- Gregory D- Jones K. Prescribing patterns for asthma by general practitioners in six European countries. Respir Med 01-JUN-2000- 94(6): 578−83
- Straand J, Sandvik H, Rokstad K. General practitioners' office consultations with elderly patients -diagnoses and prescriptions: A report from the M0re & Romsdal Prescription Study. Norwegian Journal of Epidemiology 1998- 8 (2): 121−126
- Lagerlov P. Drug prescribing data used in the assessment of general practitioners' treatment of asthma and urinary tract infection Experience from the European Drug Education Project. Norwegian Journal of Epidemiology 2001- 11 (1): 105−110
- Neville R.G., Hoskins G., Smith Π., et al. How general practitioners manage acute asthma attack.//Thorax.- 1997.- #52, — p. 153−156.
- Π‘ΡΡΠ°ΡΡΠ½ΡΠΊΠΈΠΉ Π.Π‘., ΠΠΎΠ·Π»ΠΎΠ² Π‘. Π., Π Π°ΡΠΈΠ½Π° Π‘. Π. Π€Π°ΡΠΌΠ°ΠΊΠΎΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡ: ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ ΠΏΠΎΠ½ΡΡΠΈΡ ΠΈ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ // ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠ°ΡΠΌΠ°ΠΊΠΎΠ»ΠΎΠ³ΠΈΡ ΠΈ ΡΠ΅ΡΠ°ΠΏΠΈΡ. 2001, № 10(4). — Π‘. 48−53.
- Asthma in America web site: www.asthmainamerica.com
- Janson C, Chinn S, Jarvis D, Burney P. Individual use of antiasthmatic drugs in the European Community Respiratory Health Survey. Eur Respir J. 1998 Sep-12(3):557−63.
- Janson C, Chinn S, Jarvis D, Burney P. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J. 1997 Aug-10(8):1795−802.
- Janson C, Chinn S, Jarvis D, Burney P. Individual use of antiasthmatic drugs in the European Community Respiratory Health Survey. Eur Respir J. 1998 Sep-12(3):557−63.
- Castellsague J, Garcia-Rodriguez LA, Perez-Gutthann S, Agostinis L, Cattaruzi C, Troncon MG. Characteristics of users of inhaled long-acting beta 2-agonists in a southern European population. Respir Med. 1999 0ct-93(10):709−14
- Anis AH, Lynd LD, Wang XH, King G, Spinelli JJ, Fitzgerald M, Bai T, Pare P. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ. 2001 Mar 6−164(5):625−31.
- Gerdtham UG, Hertzman P, Jonsson B, Boman G. Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden 1978 to 1991. Med Care. 1996 Dec-34(12):1188−98.
- Ishihara K, Hasegawa T, Nishimura T, Okazaki M, Katakami N, Umeda B. Increased use of inhaled corticosteroids and reduced hospitalizations in adult asthmatics: 11 years' experience in a Japanese hospital. Respirology. 1998 Sep-3(3):193−7
- Duarte MC, Camargos PA. Use of prophylactic medication in persistent asthma. J Pediatr (Rio J). 1999 Nov-Dec-75(6):456−62.
- Chen CY, Chiu HF, Yeh MK, Chang CC, Yang CY. The use of anti-asthmatic medications among pediatric patients in Taiwan. Pharmacoepidemiol Drug Saf. 2003 Mar- 12(2): 129−33.
- Jacobson GA, Peterson GM. Prescribing trends for anti-asthma drugs in Tasmania following the National Asthma Campaign. J Clin Pharm Ther. 1996 Oct-21(5):317−24
- Van Sickle D, Wright AL. Navajo perceptions of asthma and asthma medications: clinical implications. Pediatrics. 2001 Jul- 108(1):E11.
- Kozyrskyj AL, Mustard CA, Simons FE. Socioeconomic status, drug insurance benefits, and new prescriptions for inhaled corticosteroids in schoolchildren with asthma. Arch Pediatr Adolesc Med. 2001 Nov- 155(11):1219−24.
- Paterson NA, Peat JK, Mellis CM, Xuan W, Woolcock AJ. Accuracy of asthma treatment in schoolchildren in NSW, Australia. Eur Respir J. 1997 Mar-10(3):658−64
- Gilberg K, Laouri M, Wade S, Isonaka S. Analysis of medication use patterns: apparent overuse of antibiotics and underuse of prescription drugs for asthma, depression, and CHF. J Manag Care Pharm. 2003 May-Jun-9(3):232−7.
- Yuksel N, Ginther S, Man P, Tsuyuki RT. Underuse of inhaled corticosteroids in adults with asthma. Pharmacotherapy. 2000 Apr-20(4):387−93.
- Cerveri I, Zoia MC, Bugiani M, Corsico A, Carosso A, Piccioni P, Casali L, De Marco R. Inadequate antiasthma drug use in the north of Italy. Eur Respir J. 1997 Dec-10(12):2761−5.
- Gillissen A, Lecheler J. Corticophobia in asthma. Article in German. Med Klin (Munich). 2003 Aug 15−98(8):417−22.
- Janson C, Chinn S, Jarvis D, Burney P. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J. 1997 Aug-10(8):1795−802.
- International Consensus Report on Diagnosis and Treatment of Asthma: National Heart, Lung and Blood Institute, National Institutes of Health. NIH publication № 92−30−91 // Eur. Respir. J.- 1992, — # 5, — p. 601−641.
- Habbick B, Baker MJ, McNutt M, Cockcroft DW. Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan. CMAJ. 1995 Nov 15- 153(10): 1437−43.
- Gislason T, Olafsson O, Sigvaldason A. Users of antiasthma drugs in Iceland: a drug utilization study. Eur Respir J. 1997 Jun-10(6):1230−4.
- De Boeck K, Alifier M, Warmer G. Is the correct use of a dry powder inhaler (Turbohaler) age dependent? J Allergy Clin Immunol. 1999 May-103(5 Pt 1):763−7
- Holden J, Wilson R. The quality of prescribing in general practice. Int J Health Care Qual Assur. 1996−9(5):17−23.
- Linde Π, Jobst Π, Panton J. Acupuncture for chronic asthma (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.
- Linde K, Jobst Π A. Homeopathy for chronic asthma (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.
- Beamon S, Falkenbach A, Fainburg G, Linde K. Speleotherapy for asthma (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software
- ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΠ° «ΠΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½Π°Ρ Π°ΡΡΠΌΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ. Π‘ΡΡΠ°ΡΠ΅Π³ΠΈΡ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ°». Π.: 1997. 93 Ρ.
- Holloway E, Ram FSF. Breathing exercises for asthma (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.
- Hammarquist C, Burr ML, Gotzsche PC. House dust mite control measures for asthma (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.
- Campbell F, Jones K. Feather versus non-feather bedding for asthma (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.
- Kyngas H.A. Compliance of adolescents with asthma. // Nurs Health Sci. 1999. — Vol. 1(3). -P. 195−202.
- Staudenmayer, Π, Harris, PS, Seiner, JC (1981) Evaluation of a self-help education-exercise program for asthmatic children and their parents: six-month follow-up. J Asthma 18,1−5
- Hindi-Alexander, MC, Cropp, GJ (1984) Evaluation of a family asthma program. J Allergy Clin Immunol 74(4 pt 1), 505−51
- Allen, RM, Jones, MP, Oldenburg, Π (1995) Randomised trial of an asthma self-management programme for adults. Thorax 50,731−738
- Bailey, WC, Richards, JM, Jr, Brooks, CM, et al (1990) A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med 150,1664−1668
- Bolton, MB, Tilley, ΠΠ‘, Kuder, J, et al (1991) The cost and effectiveness of an education program for adults who have asthma. J Gen Intern Med 6,401−407
- Evans, D, Clark, NM, Feldman, CH, et al (1987) A school health education program for children with asthma aged 8−11 years. Health EducQ 14,267−279
- Gibson, PG, Coughlan, J, Wilson, AJ, et al (2000) Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev, CD001117
- Barnes GR, Chapman KR. Asthma education: the United Kingdom experience. Chest. 1994 Oct- 106(4 Suppl):216S-218S.
- Cote J, Golding J, Barnes G, Boulet LP. Educating the educators. How to improve teaching about asthma. Chest. 1994 Oct- 106(4 Suppl):242S-247S
- Clark N.M., Partridge M.R. Srengthening Asthma Education to Enhance Disease Control. Chest. 2002−121:1661−1669
- NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. NIH Publication No. 02−3659. February 2002- p. 1−177
- NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. NIH Publication No. 02−3659. February 2002- p. 1−177
- Canadian asthma consensus report, 1999. CMAJ 1999- 161 11 Suppl.,
- Canadian asthma consensus report, 1999. CMAJ 1999- 161 11 Suppl.,
- Kable S, Henry R, Ireland M, Cockburn J. Are the components of the Asthma Management Plan important in managing childhood asthma? A survey of general practitioners. Aust Fam Physician. 2003 Jun-32(6):470−2, 480.
- Croft D.R. and Peterson M.W. An Evaluation of the Quality and Contents of Asthma Education on the World Wide Web. Chest. 2002−121:1301−1307
- M R Partridge. Written asthma action plans. Thorax 2004−59:87−88
- ΠΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½Π°Ρ Π°ΡΡΠΌΠ°, Π³Π»ΠΎΠ±Π°Π»ΡΠ½Π°Ρ ΡΡΡΠ°ΡΠ΅Π³ΠΈΡ. ΠΡΠ½ΠΎΠ²Π½ΡΠ΅ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ Π°ΡΡΠΌΡ: ΠΡΠ΅ΠΌΠΈΡΠ½Π°Ρ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ ΡΠ°Π½Π΅Π½ΠΈΡ, ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΉ ΠΈΠ½ΡΡΠΈΡΡΡ ΡΠ΅ΡΠ΄ΡΠ΅, Π»Π΅Π³ΠΊΠΈΠ΅ ΠΈ ΠΊΡΠΎΠ²Ρ. ΠΠ°ΡΡ 1993. ΠΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ 1996- ΠΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅ 1: 1−165.
- Gibson PG, Powell Π, Coughlin J, et al. Self-management education and regular practitioner review for adults with asthma (Cochrane review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2003.
- Hargreave FE, Dolovich J, Newhouse MT. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol 1990−85:1098−111.
- Matheson M, Wicking J, Raven J, et al. Asthma management: how effective is it in the community? Intern Med J 2002−32:451−6
- Hartet TV, Windoss HH, Peebles RS Jr, et al. Inadequate out-patient medical therapy for patients with asthma admitted to two urban hospitals. Am J Med 1996−100:386−94
- Marks GB, Burney PG, Premaratne UN, et al. Asthma in Greenwich UK: impact of the disease and current management practices. Eur Respir J 1997−10:1224−9
- Gibson P.G. and Powell H. Written action plans for asthma: an evidence-based review of the key components Thorax 2004−59:94−99
- Π§ΡΡΠ°Π»ΠΈΠ½ Π.Π. ΠΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½Π°Ρ Π°ΡΡΠΌΠ°//Π., 1997.-Π’.1.- Π‘.4−5
- Π§ΡΡΠ°Π»ΠΈΠ½ Π.Π., Π¦ΠΎΠΉ Π.Π., ΠΡΡ ΠΈΠΏΠΎΠ² Π. Π. Π€Π°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ Π°ΡΡΠΌΡ Ρ ΠΏΠΎΠ·ΠΈΡΠΈΠΈ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Ρ Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΡΡΠ². Π’Π΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°ΡΡ ΠΈΠ², 2003, 3, Ρ. 73−77
- Π§ΡΡΠ°Π»ΠΈΠ½ Π.Π., Π¦ΠΎΠΉ Π.Π., ΠΡΡ ΠΈΠΏΠΎΠ² Π. Π. ΠΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠ½Π°Ρ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Π° ΠΈ Π΅Π΅ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π² ΠΏΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΠΈ (Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΡ). ΠΡΡΠ½Π°Π» «ΠΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ», 2002, 2, 67−74
- International Consensus Report on Diagnosis and Treatment of Asthma: National Heart, Lung and Blood Institute, National Institutes of Health. NIH publication № 92−30−91// Eur. Respir. J.-1992.-# 5, — p. 601−641.
- ΠΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½Π°Ρ Π°ΡΡΠΌΠ°, Π³Π»ΠΎΠ±Π°Π»ΡΠ½Π°Ρ ΡΡΡΠ°ΡΠ΅Π³ΠΈΡ. ΠΡΠ½ΠΎΠ²Π½ΡΠ΅ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ Π°ΡΡΠΌΡ: ΠΡΠ΅ΠΌΠΈΡΠ½Π°Ρ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ ΡΠ°Π½Π΅Π½ΠΈΡ, ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΉ ΠΈΠ½ΡΡΠΈΡΡΡ ΡΠ΅ΡΠ΄ΡΠ΅, Π»Π΅Π³ΠΊΠΈΠ΅ ΠΈ ΠΊΡΠΎΠ²Ρ. ΠΠ°ΡΡ 1993. ΠΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ 1996- ΠΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅ 1:1−165.
- North of England evidence based guidelines development project: summary version of methods of evidence based guideline for the primary care management of asthma in adults// BMJ.- 1996.-# 312, — p. 762−766.
- Beveridge R.C., Grunfeld A.F., Hodder R.V., et al. Guidelines for the emergency management of asthma in adults.// Can. Med. Association J.- 1996.- Vol. 155, — p. 25−37.
- Canadian asthma consensus report, 1999. CMAJ 1999- 161 11 Suppl.- p. 1−62.
- Difficult/therapy-resistant asthma. Eur. Respir. J. 1999- 13:1198−1208.
- Barnes P.J., Woolcock A.J. Difficult asthma// Eur. Respir. J.- 1998.-#12, — p.1209−1218.
- Lipworth B. Treatment of acute asthma. Lancet, 1997, 350 (suppl. II), 18−23.
- Π‘ΡΠ°Π½Π΄Π°ΡΡΡ (ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Ρ) Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ Π½Π΅ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ Π»Π΅Π³ΠΊΠΈΡ . ΠΠΎΠ΄ ΡΠ΅Π΄. Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΊΠ° Π ΠΠΠ Π. Π. Π§ΡΡΠ°Π»ΠΈΠ½Π°. Π., ΠΠ·Π΄Π°ΡΠ΅Π»ΡΡΡΠ²ΠΎ ΠΡΠ°Π½ΡΡ. 1999, 40 Ρ.
- Π§ΡΡΠ°Π»ΠΈΠ½ Π.Π., ΠΠ΅Π΄Π½ΠΈΠΊΠΎΠ² Π. Π., ΠΠ΅Π»Π΅Π²ΡΠΊΠΈΠΉ Π. Π‘. Ρ ΡΠΎΠ°Π²Ρ. ΠΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½Π°Ρ Π°ΡΡΠΌΠ°: ΡΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ Π΄Π»Ρ Π²ΡΠ°ΡΠ΅ΠΉ Π ΠΎΡΡΠΈΠΈ.//Consilium medicum. -2000. -Π’. 2. № 1. — Π‘. 11−21
- ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΠ° «ΠΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½Π°Ρ Π°ΡΡΠΌΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ. Π‘ΡΡΠ°ΡΠ΅Π³ΠΈΡ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ°» Π ΠΠ, ΠΏΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅, ΠΌΠ°ΠΉ 1998- 6 (2): 3−48.
- NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. NIH Publication No. 02−3659. February 2002- p. 1−177
- Smeele IJ, Grol RP, van Schayck CP, van den Bosch WJ, van den Hoogen HJ, Muris JW. Can small group education and peer review improve care for patients with asthma/chronic obstructive pulmonary disease? Qual Health Care 1999−8:92−8
- Donahue JG, Weiss ST, Goetsch MA, Livingston JM, Greineder DK, Piatt R. Assessment of asthma using automated and full-text medical records. J Asthma. 1997−34(4):273−81.
- Cunha AJ, Santos MA, Galvao MG, Ibiapina AA. Knowledge of pediatricians in Rio de Janeiro, Brazil, about inhalation therapy in asthmatic children. Allergol Immunopathol (Madr). 2003 Mar-Apr-31(2):87−90.
- Ingvardsen BK, Kampmann JM, Laursen LC, Johansen HL. Utilization of anti-asthmatic drugs among Danish children in 1998. Article in Danish. Ugeskr Laeger. 2000 Nov 6−162(45):6062−5.
- Davis P, Man P, Cave A, McBennett S, Cook D. Use of focus groups to assess the educational needs of the primary care physician for the management of asthma. Med Educ. 2000 Dec-34(12):987−93.
- Zoorab R, Wormuth C, McCarthy-Larzelere M. Asthma: knowledge and practice patterns of Louisiana family physicians. J La State Med Soc. 2002 May-Jun-154(3):136−40.
- Kahan E, Weingarten MA, Appelbaum T. Attitudes of primary care physicians to the management of asthma and their perception of its relationship to patients' work. Isr J Med Sci. 1996 Sep-32(9):757−62.
- Neville RG, Hoskins G, Smith B, Clark RA. Observations on the structure, process and clinical outcomes of asthma care in general practice. Br J Gen Pract 1996−46:583−7.
- Neville RG. Effective asthma audit. The Practitioner 1995−239:203−5.
- NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. NIH Publication No. 02−3659. February 2002- p. 84.
- Cain WT, Cable G, Oppenheimer JJ. The ability of the community pharmacist to learn the proper actuation techniques of inhaler devices. J Allergy Clin Immunol 2001−108:918−20.
- Self TH, Brooks JB, Lieberman P, Ryan MR. The value of demonstration and the role of the pharmacist in teaching the correct use of pressurized bronchodilators. Can Med Assoc J 1998−128:129−31.
- Kesten S, Zive K, Chapman KR. Pharmacist knowledge and ability to use inhaled medication delivery systems. Chest 1993−104:1737−42.
- Mickel TR, Self TS, Farr GE, Bess DT, Tsiu SJ, Caldwell FLF. Evaluation of pharmacists' practice in patient education when dispensing a metered-dose inhaler. Drug Intell Clin Pharm 1990−24:927−30.
- Andres Jacome J, Inesta Garcia A. Prospective study about the impact of a community pharmaceutical care service in patients with asthma. Rev Esp Salud Publica. 2003 May-Jun-77(3):393−403.
- Erhola M, Makinen R, Koskela K, Bergman V, Klaukka T, Makela M, Tirkkonen L, Kaila M. The asthma programme of Finland: an evaluation survey in primary health care. Int J Tuberc Lung Dis. 2003 Jun-7(6):592−8.
- Wright J, Warren E, Reeves J, Bibby J, Harrison S, Dowswell G, Russell I, Russell D. Effectiveness of multifaceted implementation of guidelines in primary care. J Health Serv Res Policy. 2003 Jul-8(3):142−8.
- Π§ΡΡΠ°Π»ΠΈΠ½ Π.Π. ΠΠ΅Π»Π°Ρ ΠΊΠ½ΠΈΠ³Π°. ΠΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ. Π ΠΎΡΡΠΈΡ 2003. Π: 2003. ΡΡΡ. 51−56. www.pulmonology.ru
- ΠΠ΄ΠΎΡΠΎΠ²ΡΠ΅ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ Π ΠΎΡΡΠΈΠΈ ΠΈ Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΡΡΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠΉ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ ΡΠ°Π½Π΅Π½ΠΈΡ Π² 2002 Π³. (2003 Π³.) (ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ). Π., 2002 (2003)
- ΠΠ΅ΡΠ΅Π½ΠΊΠΎ Π.Π. Π Π°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΡ Π² Π‘Π²Π΅ΡΠ΄Π»ΠΎΠ²ΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ. ΠΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ 2001 Π³. № 2 ΡΡΡ.50−55
- ΠΠΈΠ»ΠΈΡΠ΅Π½ΠΊΠΎ Π’.Π. Π Π°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π±ΡΠΎΠ½Ρ ΠΈΡΠ° ΠΈ Π΄ΡΡΠ³ΠΈΡ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΡ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ ΡΡΠ΅Π΄ΠΈ Π²Π·ΡΠΎΡΠ»ΠΎΠ³ΠΎ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ, ΠΈΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ (ΠΠΏΠΈΠ½ΠΈΠΊΠΎ-ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅): ΠΠ²ΡΠΎΡΠ΅Ρ. Π΄ΠΈΡΡ. ΠΊΠ°Π½Π΄. ΠΌΠ΅Π΄, Π½Π°ΡΠΊ. Π., 1992
- ΠΠΈΠ»ΠΈΡΠ΅Π½ΠΊΠΎ Π’.Π. ΠΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΡ // ΠΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½Π°Ρ Π°ΡΡΠΌΠ°/ ΠΠΎΠ΄ ΡΠ΅Π΄. Π. Π. Π§ΡΡΠ°Π»ΠΈΠ½Π°. Π.: ΠΠ³Π°Ρ, 1997. — Π’. 1, ΠΠ». 14. — Π‘.400 — 423
- ΠΠΈΠ»ΠΈΡΠ΅Π½ΠΊΠΎ Π’.Π. Π Π°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π±ΡΠΎΠ½Ρ ΠΈΡΠ° ΠΈ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΡ (Π΄Π°Π½Π½ΡΠ΅ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ). ΠΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ 1994- 5(1): 78−83
- NHLBI/WHO Workshop Report Op. cit.
- Π€Π΅Π΄Π΅ΡΠ°Π»ΡΠ½ΠΎΠ΅ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ ΠΏΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ ΡΡΠ΅Π΄ΡΡΠ² (ΡΠΎΡΠΌΡΠ»ΡΡΠ½Π°Ρ ΡΠΈΡΡΠ΅ΠΌΠ°). ΠΡΠΏΡΡΠΊ IV. ΠΠΎΡΠΊΠ²Π° 2003 Π³: Ρ. 194−195
- Π‘ΡΠ°Π½Π΄Π°ΡΡΡ (ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Ρ) Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ Π½Π΅ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ Π»Π΅Π³ΠΊΠΈΡ . ΠΠΎΠ΄ ΡΠ΅Π΄. Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΊΠ° Π ΠΠΠ Π. Π. Π§ΡΡΠ°Π»ΠΈΠ½Π°. Π., ΠΠ·Π΄Π°ΡΠ΅Π»ΡΡΡΠ²ΠΎ ΠΡΠ°Π½ΡΡ. 1999, 40 Ρ.
- Π‘ΡΠ°Π½Π΄Π°ΡΡΡ (ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Ρ) Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ Π½Π΅ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ Π»Π΅Π³ΠΊΠΈΡ . ΠΠΎΠ΄ ΡΠ΅Π΄. Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΊΠ° Π ΠΠΠ Π. Π. Π§ΡΡΠ°Π»ΠΈΠ½Π°. Π., ΠΠ·Π΄Π°ΡΠ΅Π»ΡΡΡΠ²ΠΎ ΠΡΠ°Π½ΡΡ. 1999, 40 Ρ.
- Juniper EF et al., ΠΎΡ. cit.
- Π€Π΅Π΄Π΅ΡΠ°Π»ΡΠ½ΠΎΠ΅ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ ΠΏΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ ΡΡΠ΅Π΄ΡΡΠ² (ΡΠΎΡΠΌΡΠ»ΡΡΠ½Π°Ρ ΡΠΈΡΡΠ΅ΠΌΠ°). ΠΡΠΏΡΡΠΊ IV. ΠΠΎΡΠΊΠ²Π° 2003 Π³: Ρ. 194−195
- ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΠ° «ΠΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½Π°Ρ Π°ΡΡΠΌΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ. Π‘ΡΡΠ°ΡΠ΅Π³ΠΈΡ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ°» Π ΠΠ, ΠΏΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅, ΠΌΠ°ΠΉ 1998- 6 (2): 3−48.
- Π‘ΡΠ°Π½Π΄Π°ΡΡΡ (ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Ρ) Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ Π½Π΅ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ Π»Π΅Π³ΠΊΠΈΡ . ΠΠΎΠ΄ ΡΠ΅Π΄. Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΊΠ° Π ΠΠΠ Π. Π. Π§ΡΡΠ°Π»ΠΈΠ½Π°. Π., ΠΠ·Π΄Π°ΡΠ΅Π»ΡΡΡΠ²ΠΎ ΠΡΠ°Π½ΡΡ. 1999, 40 Ρ.
- NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. NIH Publication No. 02−3659. February 2002- p. 1−177
- ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΠ° «ΠΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½Π°Ρ Π°ΡΡΠΌΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ. Π‘ΡΡΠ°ΡΠ΅Π³ΠΈΡ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ°» Π ΠΠ, ΠΏΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅, ΠΌΠ°ΠΉ 1998- 6 (2): 3−48.
- Juniper EF et al., op. cit.202 11. Juniper EF, O’Byme PM, Guyatt CH et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999- 14: 902−907